BIOMAT Database Logo BIOMAT Database Logo

Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia. 2016

Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Children's Hospital of Philadelphia (CHOP), Department of Pediatrics, Division of Hematology, PA.

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D000077543 Deferiprone A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA. 1,2-Dimethyl-3-hydroxy-4-pyridinone,1,2-Dimethyl-3-hydroxypyrid-4-one,1,2-Dimethyl-3-hydroxypyridin-4-one,3-Hydroxy-1,2-dimethyl-4-pyridinone,DMOHPO,Ferriprox,HDMPP,1,2 Dimethyl 3 hydroxy 4 pyridinone,1,2 Dimethyl 3 hydroxypyrid 4 one,1,2 Dimethyl 3 hydroxypyridin 4 one,3 Hydroxy 1,2 dimethyl 4 pyridinone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D017086 beta-Thalassemia A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent. Anemia, Cooley's,Anemia, Erythroblastic,Anemia, Mediterranean,Hemoglobin F Disease,Thalassemia Major,Thalassemia Minor,Erythroblastic Anemia,Mediterranean Anemia,Microcytemia, beta Type,Thalassemia Intermedia,Thalassemia Major (beta-Thalassemia Major),Thalassemia Minor (beta-Thalassemia Minor),Thalassemia, beta Type,beta Thalassemia,Anemia, Cooley,Anemia, Cooleys,Anemias, Erythroblastic,Anemias, Mediterranean,Cooley's Anemia,Disease, Hemoglobin F,Intermedia, Thalassemia,Intermedias, Thalassemia,Major, Thalassemia (beta-Thalassemia Major),Majors, Thalassemia (beta-Thalassemia Major),Mediterranean Anemias,Microcytemias, beta Type,Minor, Thalassemia (beta-Thalassemia Minor),Minors, Thalassemia (beta-Thalassemia Minor),Thalassemia Intermedias,Thalassemia Major (beta Thalassemia Major),Thalassemia Majors (beta-Thalassemia Major),Thalassemia Minor (beta Thalassemia Minor),Thalassemia Minors (beta-Thalassemia Minor),Thalassemia, beta,Thalassemias, beta,Thalassemias, beta Type,Type Microcytemia, beta,Type Microcytemias, beta,Type Thalassemia, beta,Type Thalassemias, beta,beta Thalassemias,beta Type Microcytemia,beta Type Microcytemias,beta Type Thalassemia,beta Type Thalassemias
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.
April 2015, American journal of hematology,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
January 2020, Journal of Alzheimer's disease : JAD,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
January 2020, Journal of Alzheimer's disease : JAD,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
June 2018, American journal of hematology,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Retraction to: The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
January 2023, Journal of Alzheimer's disease : JAD,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload.
January 2010, Advances in hematology,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Iron balance and the management of iron overload in beta-thalassemia intermedia.
January 1988, Birth defects original article series,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
November 1981, European journal of pediatrics,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
February 2013, Blood,
Carla Casu, and Mariam Aghajan, and Paraskevi Rea Oikonomidou, and Shuling Guo, and Brett P Monia, and Stefano Rivella
Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
July 2023, Blood advances,
Copied contents to your clipboard!